Modern possibilities of sodium hyaluronate in tear substitutive therapy of patients with “dry eye” syndrome

<b><br> </b><br> V.V. Brzheskiy, V.Yu. Popov<br> <br> St. Petersburg State Pediatric Medical University, Saint Petersburg, Russian Federation<br> <br> At present, artificial tear preparations based on sodium hyaluronate account for 53.3% of the t...

Full description

Bibliographic Details
Main Authors: V.V. Brzheskiy, V.Yu. Popov
Format: Article
Language:Russian
Published: Prime-Media 2019-01-01
Series:РМЖ "Клиническая офтальмология"
Online Access:http://clinopht.com/upload/iblock/b95/b95def167eed86f698755c424231b17c.pdf
id doaj-36ef23bec01145ee9e37ae42ec683438
record_format Article
spelling doaj-36ef23bec01145ee9e37ae42ec6834382021-09-16T13:40:15ZrusPrime-Media РМЖ "Клиническая офтальмология"2311-77292619-15712019-01-0118430552Modern possibilities of sodium hyaluronate in tear substitutive therapy of patients with “dry eye” syndromeV.V. Brzheskiy0V.Yu. Popov1Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399<b><br> </b><br> V.V. Brzheskiy, V.Yu. Popov<br> <br> St. Petersburg State Pediatric Medical University, Saint Petersburg, Russian Federation<br> <br> At present, artificial tear preparations based on sodium hyaluronate account for 53.3% of the total of 45 tear substitutes registered in Russia, of which 72.7% are from 22 of their non-preservative forms. The positive properties of hyaluronic acid (hygroscopicity, mucoadhesiveness, high tolerability when instilled into the conjunctival cavity) provide long-lasting hydration of an eye surface during its xerosis and cause high clinical efficacy in the treatment of patients with “dry eye” syndrome (DES).<br> The same properties are naturally possessed by such preparations as Vismed, Vismed light, Vismed multi and Vismed gel, based on the sodium salt of the high molecular weight hyaluronic acid. In a number of experimental studies, the efficacy and safety of the Vismed line is proved: in vitro — on the culture of epithelial cells of the human conjunctiva, in vivo — on the model of traumatic corneal erosion in rabbits. The results of the experiments were further confirmed by clinical studies in the treatment of patients with DES of various origins. In this case, the Vismed line was more effective than solutions of carboxymethylcellulose, hydroxypropylmethylcellulose, carbomer 934P, and other compounds widely used in tear substitutive therapy.<br> <br> <b>Key words:</b> hyaluronic acid, artificial tear preparations, “dry eye” syndrome, Vismed.<br> <b>For citation:</b> Brzheskiy V.V., Popov V.Yu. Modern possibilities of sodium hyaluronate in tear substitutive therapy of patients with&nbsp;<br> “dry eye”syndrome. RMJ “Clinical ophthalmology”. 2018;4:179–185.<br>http://clinopht.com/upload/iblock/b95/b95def167eed86f698755c424231b17c.pdf
collection DOAJ
language Russian
format Article
sources DOAJ
author V.V. Brzheskiy
V.Yu. Popov
spellingShingle V.V. Brzheskiy
V.Yu. Popov
Modern possibilities of sodium hyaluronate in tear substitutive therapy of patients with “dry eye” syndrome
РМЖ "Клиническая офтальмология"
author_facet V.V. Brzheskiy
V.Yu. Popov
author_sort V.V. Brzheskiy
title Modern possibilities of sodium hyaluronate in tear substitutive therapy of patients with “dry eye” syndrome
title_short Modern possibilities of sodium hyaluronate in tear substitutive therapy of patients with “dry eye” syndrome
title_full Modern possibilities of sodium hyaluronate in tear substitutive therapy of patients with “dry eye” syndrome
title_fullStr Modern possibilities of sodium hyaluronate in tear substitutive therapy of patients with “dry eye” syndrome
title_full_unstemmed Modern possibilities of sodium hyaluronate in tear substitutive therapy of patients with “dry eye” syndrome
title_sort modern possibilities of sodium hyaluronate in tear substitutive therapy of patients with “dry eye” syndrome
publisher Prime-Media
series РМЖ "Клиническая офтальмология"
issn 2311-7729
2619-1571
publishDate 2019-01-01
description <b><br> </b><br> V.V. Brzheskiy, V.Yu. Popov<br> <br> St. Petersburg State Pediatric Medical University, Saint Petersburg, Russian Federation<br> <br> At present, artificial tear preparations based on sodium hyaluronate account for 53.3% of the total of 45 tear substitutes registered in Russia, of which 72.7% are from 22 of their non-preservative forms. The positive properties of hyaluronic acid (hygroscopicity, mucoadhesiveness, high tolerability when instilled into the conjunctival cavity) provide long-lasting hydration of an eye surface during its xerosis and cause high clinical efficacy in the treatment of patients with “dry eye” syndrome (DES).<br> The same properties are naturally possessed by such preparations as Vismed, Vismed light, Vismed multi and Vismed gel, based on the sodium salt of the high molecular weight hyaluronic acid. In a number of experimental studies, the efficacy and safety of the Vismed line is proved: in vitro — on the culture of epithelial cells of the human conjunctiva, in vivo — on the model of traumatic corneal erosion in rabbits. The results of the experiments were further confirmed by clinical studies in the treatment of patients with DES of various origins. In this case, the Vismed line was more effective than solutions of carboxymethylcellulose, hydroxypropylmethylcellulose, carbomer 934P, and other compounds widely used in tear substitutive therapy.<br> <br> <b>Key words:</b> hyaluronic acid, artificial tear preparations, “dry eye” syndrome, Vismed.<br> <b>For citation:</b> Brzheskiy V.V., Popov V.Yu. Modern possibilities of sodium hyaluronate in tear substitutive therapy of patients with&nbsp;<br> “dry eye”syndrome. RMJ “Clinical ophthalmology”. 2018;4:179–185.<br>
url http://clinopht.com/upload/iblock/b95/b95def167eed86f698755c424231b17c.pdf
work_keys_str_mv AT vvbrzheskiy modernpossibilitiesofsodiumhyaluronateintearsubstitutivetherapyofpatientswithdryeyesyndrome
AT vyupopov modernpossibilitiesofsodiumhyaluronateintearsubstitutivetherapyofpatientswithdryeyesyndrome
_version_ 1717378216374566912